Additionally, SFRP2 has been identified as a candidate tumor suppressor gene and a major contributor to tumorigenicity in colorectal [42], esophageal [43], and GC [44], where it is often silenced by promoter hypermethylation. Here, SFRP2 is linked to neoplasm.